MichaelAnthonyBologneseMD

PubMed

• 120 citations
  Effects of 24 Months of Treatment With Romosozumab Followed by 12 Months of Denosumab or Placebo in Postmenopausal Women With Low Bone Mineral Density: A Randomized, D...
  Michael R. McClung, Jacques P. Brown, Adolfo Diez-Perez, Heinrich Resch, John Caminis, Paul D Meisner, Michael A. Bolognese, Stefan Goemaere, Henry G. Bone, Jose R. Za...> ;Journal of Bone and Mineral Research. 2018 Aug 1
• 228 citations
  Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised...
  Bente L. Langdahl, Cesar Libanati, Daria B. Crittenden, Michael A. Bolognese, Jacques P. Brown, Nadia Daizadeh, Eva Dokoupilova, Klaus Engelke, Joel S. Finkelstein, Ha...> ;Lancet. 2017 Sep 30
• 58 citations
  Greater Gains in Spine and Hip Strength for Romosozumab Compared With Teriparatide in Postmenopausal Women With Low Bone Mass
  Tony M. Keaveny, Daria B. Crittenden, Michael A. Bolognese, Harry K. Genant, Klaus Engelke, Beatriz Oliveri, Jacques P. Brown, Bente L. Langdahl, Chris Yan, Andreas Gr...> ;Journal of Bone and Mineral Research. 2017 Sep 1
• 11 citations
  Influence of subject discontinuation on long-term nonvertebral fracture rate in the denosumab FREEDOM Extension study
  Jonathan D. Adachi, Henry G. Bone, Nadia Daizadeh, P. Dakin, S. Papapoulos, Peyman Hadji, Chris Recknor, Michael A. Bolognese, Andrea Wang, Celia J. F. Lin, Rachel B. ...> ;BMC Musculoskeletal Disorders. 2017 Apr 27
• 83 citations
  Effects of Romosozumab Compared With Teriparatide on Bone Density and Mass at the Spine and Hip in Postmenopausal Women With Low Bone Mass
  Harry K. Genant, Klaus Engelke, Michael A. Bolognese, Carlos Mautalen, Jacques P. Brown, Chris Recknor, Stefan Goemaere, Thomas Fuerst, Y.-C. Yang, Andreas Grauer, Ces...> ;Journal of Bone and Mineral Research. 2017 Jan 1
• 33 citations
  A Longitudinal Study of Skeletal Histomorphometry at 6 and 24 Months Across Four Bone Envelopes in Postmenopausal Women With Osteoporosis Receiving Teriparatide or Zol...
  David W. Dempster, Hua Zhou, Robert R. Recker, Jacques P. Brown, Michael A. Bolognese, Christopher Recknor, David L. Kendler, E. Michael Lewiecki, David A. Hanley, Sud...> ;Journal of Bone and Mineral Research. 2016 Jul 1
• Denosumab or Zoledronic Acid in Postmenopausal Women With Osteoporosis Previously Treated With Oral Bisphosphonates.
  Miller, P. D.,Pannacciulli, N.,Brown, J. P.,Czerwinski, E.,Nedergaard, B. S.,Bolognese, M. A.,Malouf, J.,Bone, H. G.,Reginster, J. Y.,Singer, A.,Wang, C.,Wagman, R. B....> ;J. Clin. Endocrinol. Metab.. 2016 Jun 09
• 202 citations
  A randomized, double-blind phase 2 clinical trial of blosozumab, a sclerostin antibody, in postmenopausal women with low bone mineral density
  Robert R. Recker, Charles Benson, Toshio Matsumoto, Michael A. Bolognese, Deborah A. Robins, Jahangir Alam, Alan Y Chiang, Leijun Hu, John H. Krege, Hideaki Sowa, Bruc...> ;Journal of Bone and Mineral Research. 2015 Feb 1
• 68 citations
  A 24-month study evaluating the efficacy and safety of denosumab for the treatment of men with low bone mineral density: results from the ADAMO trial.
  Bente L. Langdahl, Christence S. Teglbjaerg, P.R. Ho, Roland Chapurlat, Edward Czerwiński, David L. Kendler, Jean-Yves Reginster, Alan Kivitz, E. Michael Lewiecki, Pau...> ;The Journal of Clinical Endocrinology and Metabolism. 2015 Jan 21
• 35 citations
  Effects of up to 5 years of denosumab treatment on bone histology and histomorphometry: the FREEDOM study extension.
  Jacques P. Brown, Ian R. Reid, Rachel B. Wagman, David L. Kendler, Paul D. Miller, Jens-Erik Beck Jensen, Michael A. Bolognese, Nadia Daizadeh, Ivo Valter, David W. De...> ;Journal of Bone and Mineral Research. 2014 Sep 1
• 493 citations
  A 52-Week Placebo-Controlled Trial of Evolocumab in Hyperlipidemia
  Dirk J. Blom, Tomas Hala, Michael A. Bolognese, Michael J. Lillestol, Phillip D. Toth, Lesley J. Burgess, Richard Ceska, Eli M. Roth, Michael J. Koren, Christie M. Bal...> ;The New England Journal of Medicine. 2014 May 7
• Denosumab significantly increases bone mineral density and reduces bone turnover compared with monthly oral ibandronate and risedronate in postmenopausal women who rem...
  Brown, J. P.,Roux, C.,Ho, P. R.,Bolognese, M. A.,Hall, J.,Bone, H. G.,Bonnick, S.,van den Bergh, J. P.,Ferreira, I.,Dakin, P.,Wagman, R. B.,Recknor, C.> ;Osteoporos Int. 2014 Mar 29
• The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group.
  Siris, E. S.,Adler, R.,Bilezikian, J.,Bolognese, M.,Dawson-Hughes, B.,Favus, M. J.,Harris, S. T.,Jan de Beur, S. M.,Khosla, S.,Lane, N. E.,Lindsay, R.,Nana, A. D.,Orwo...> ;Osteoporos Int. 2014 Mar 01
• 786 citations
  Romosozumab in Postmenopausal Women with Low Bone Mineral Density
  Michael R. McClung, Andreas Grauer, Steven Boonen, Michael A. Bolognese, Jacques P. Brown, Adolfo Diez-Perez, Bente L. Langdahl, Jean-Yves Reginster, Jose R. Zanchetta...> ;The New England Journal of Medicine. 2014 Jan 29
• 167 citations
  Efficacy and Safety of Longer-Term Administration of Evolocumab (AMG 145) in Patients With Hypercholesterolemia 52-Week Results From the Open-Label Study of Long-Term ...
  Michael J. Koren, Robert P. Giugliano, Frederick J. Raal, David R. Sullivan, Michael A. Bolognese, Gisle Langslet, Fernando Civeira, Ransi Somaratne, Patric Nelson, Th...> ;Circulation. 2014 Jan 14
• 46 citations
  Improvements in hip trabecular, subcortical, and cortical density and mass in postmenopausal women with osteoporosis treated with denosumab.
  Harry K. Genant, Cesar Libanati, Klaus Engelke, Jose R. Zanchetta, Arne Hoiseth, Chui Kin Yuen, Sigtas Stonkus, Michael A. Bolognese, Edward Franek, Thomas Fuerst, Hoi...> ;Bone. 2013 Oct 1
• 103 citations
  Denosumab compared with ibandronate in postmenopausal women previously treated with bisphosphonate therapy: a randomized open-label trial.
  Chris Recknor, Edward Czerwiński, Henry G. Bone, Sydney Lou Bonnick, Neil Binkley, Santiago Palacios, Alfred H. Moffett, S. Siddhanti, Irene Ferreira, Prayashi Ghelani...> ;Obstetrics and Gynecology. 2013 Jun 1
• 23 citations
  Denosumab densitometric changes assessed by quantitative computed tomography at the spine and hip in postmenopausal women with osteoporosis.
  Michael R. McClung, Jose R. Zanchetta, Arne Hoiseth, David L. Kendler, Chui Kin Yuen, Jacques P. Brown, Sigtas Stonkus, Stefan Goemaere, Christopher Recknor, Grattan W...> ;Journal of Clinical Densitometry. 2013 Apr 1
• Effect of denosumab on bone mineral density and biochemical markers of bone turnover: 8-year results of a phase 2 clinical trial.
  McClung, M. R.,Lewiecki, E. M.,Geller, M. L.,Bolognese, M. A.,Peacock, M.,Weinstein, R. L.,Ding, B.,Rockabrand, E.,Wagman, R. B.,Miller, P. D.> ;Osteoporos Int. 2013 Jan
• 270 citations
  Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 as monotherapy in patients with hypercholesterolaemia (MEN...
  Michael J. Koren, Rob Scott, Jae B. Kim, Beat Knusel, Thomas Liu, Lei Lei, Michael A. Bolognese, Scott M. Wasserman> ;Lancet. 2012 Dec 8
• 98 citations
  A phase 3 trial of the efficacy and safety of oral recombinant calcitonin: The oral calcitonin in postmenopausal osteoporosis (ORACAL) trial
  Neil Binkley, Michael A. Bolognese, Anna Sidorowicz-Bialynicka, Tasneem Vally, Richard Trout, Colin G. Miller, Christine E Buben, James P. Gilligan, David S. Krause> ;Journal of Bone and Mineral Research. 2012 Aug 1
• 124 citations
  A randomized, placebo-controlled study of the effects of denosumab for the treatment of men with low bone mineral density
  Eric S. Orwoll, Christence S. Teglbjaerg, Bente L. Langdahl, Roland Chapurlat, Edward Czerwiński, David L. Kendler, Jean-Yves Reginster, Alan Kivitz, E. Michael Lewiec...> ;The Journal of Clinical Endocrinology and Metabolism. 2012 Jun 21
• 61 citations
  Skeletal Histomorphometry in Subjects on Teriparatide or Zoledronic Acid Therapy (SHOTZ) Study: A Randomized Controlled Trial
  David W. Dempster, Hua Zhou, Robert R. Recker, Jacques P. Brown, Michael A. Bolognese, Christopher Recknor, David L. Kendler, E. Michael Lewiecki, David A. Hanley, D. ...> ;The Journal of Clinical Endocrinology and Metabolism. 2012 Jun 14
• 127 citations
  Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fractures.
  M. Austin, Y.-C. Yang, Eric Vittinghoff, Silvano Adami, Steven Boonen, Douglas C. Bauer, Gerolamo Bianchi, Michael A. Bolognese, Claus Christiansen, Richard Eastell, A...> ;Journal of Bone and Mineral Research. 2012 Mar 1
• 35 citations
  Denosumab significantly increases DXA BMD at both trabecular and cortical sites: results from the FREEDOM study.
  Michael A. Bolognese, Christence S. Teglbjaerg, Jose R. Zanchetta, Kurt Lippuner, Michael R. McClung, Maria Luisa Brandi, Arne Hoiseth, Peter L. Lakatos, Alfred H. Mof...> ;Journal of Clinical Densitometry. 2011 Apr 1
• Join now to see all